Search alternatives:
significant level » significance level (Expand Search), significance levels (Expand Search), significant gender (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
teer decrease » mean decrease (Expand Search)
significant level » significance level (Expand Search), significance levels (Expand Search), significant gender (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
teer decrease » mean decrease (Expand Search)
-
1441
-
1442
-
1443
-
1444
Unsupervised hierarchical clustering for benign samples only (nontreatment, STT, and LTT groups).
Published 2025Subjects: -
1445
-
1446
-
1447
Combined Morphological and IHC Data: Combined Morphological and Immunohistochemistry Data.
Published 2025Subjects: -
1448
-
1449
Morphologic changes after dihydrotestosterone (DHT) treatment.1A: Diffuse lobular atrophy (20x).
Published 2025Subjects: -
1450
-
1451
-
1452
-
1453
Logistic Regression Analysis of the Association between PALs (MET-minutes/week) and CVD.
Published 2025Subjects: -
1454
-
1455
IHC Scores computer image analysis: Immunohistochemistry Scores and computer image analysis.
Published 2025Subjects: -
1456
-
1457
-
1458
-
1459
-
1460